News

Verywell Health on MSN1d
Wegovy vs. Ozempic: Which Is the Better Weight Loss Drug?
Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and ...
Parade on MSN12h
Wegovy Could Be Silently Treating a Serious Health Risk You Didn't Know You Had
According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 ...
Managed Healthcare Executive6d
FDA Sets Action Date for Oral Wegovy for Weight Loss
A decision is expected in the fourth quarter of 2025.
Everyday Health on MSN7d
Wegovy May Halt and Even Reverse Severe Liver Disease
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
NJBIZ2d
Novo Nordisk seeks FDA approval for Wegovy weight loss pill
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
The Pharma Letter2d
FDA accepts filing application for oral Wegovy 25mg
The US Food and Drug Administration (FDA) accepted Novo Nordisk’s New Drug Application (NDA) submission for an ...
Pharmaceutical Technology on MSN3d
FDA accepts Novo Nordisk’s NDA submission for weight management therapy
The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...
Managed Healthcare Executive7d
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Morningstar6d
FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity
25 mg oral formulation of Wegovy® (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major ...